SCAI statement on drug-eluting stents: practice and health care delivery implications.
Hodgson
John McB
JM
Heart and Vascular Center, MetroHealth Medical Center, Cleveland, Ohio 44109, USA. jhodgson@metrohealth.org
King
Spencer B
SB
Feldman
Ted
T
Cowley
Michael J
MJ
Klein
Lloyd W
LW
Babb
Joseph D
JD
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000592:standards; D003695:Delivery of Health Care / Q000592:standards*; D004333:Drug Administration Routes; D006083:Graft Occlusion, Vascular / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D010818:Practice Patterns, Physicians' / Q000592:standards*; D015607:Stents / Q000009:adverse effects / Q000592:standards*
D020533:Angiogenesis Inhibitors; D007166:Immunosuppressive Agents